This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB06714/identifier/kegg-drug/
n8http://linked.opendata.cz/resource/drugbank/drug/DB06714/identifier/drugbank/
n15http://linked.opendata.cz/resource/drugbank/dosage/
n16http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n11http://linked.opendata.cz/resource/drugbank/drug/DB06714/identifier/wikipedia/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://linked.opendata.cz/resource/drugbank/drug/DB06714/identifier/pharmgkb/
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n4http://linked.opendata.cz/resource/drugbank/drug/DB06714/identifier/pubchem-compound/
n7http://linked.opendata.cz/resource/drugbank/drug/DB06714/identifier/pubchem-substance/

Statements

Subject Item
n2:DB06714
rdf:type
n5:Drug
n5:description
Propylhexedrine is an alpha-adrenergic agonist often used in nasal decongestant inhalers. It is used to give temporary relief for nasal congestion from colds, allergic rhinitis, or allergies.
n5:dosage
n15:271B50CB-363D-11E5-9242-09173F13E4C5
n5:group
approved
n5:indication
It is used to provide temporary symptomatic relief of nasal congestion due to colds, allergies and allergic rhinitis.
owl:sameAs
n13:DB06714 n16:DB06714
dcterms:title
Propylhexedrine
adms:identifier
n4:7558 n7:99443266 n8:DB06714 n9:D05637 n10:PA165958387 n11:Propylhexedrine
n5:mechanismOfAction
Propylhexidrine causes the norepinephrine, dopamine, and serotonin (5HT) transporters to reverse their direction of flow. This inversion leads to a release of these transmitters from the vesicles to the cytoplasm and from the cytoplasm to the synapse. It also antagonizes the action of VMAT2, causing the release of more neurotransmitters.
n5:synonym
Dristan inhaler
n5:toxicity
The signs and symptoms that are produced after the acute overdosage of Propylhexidrine include Psychosis, Burning sensation.
n5:synthesisReference
"DrugSyn.org":http://www.drugsyn.org/Propylhexedrine.htm
n5:IUPAC-Name
n6:271B50D0-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B50D6-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B50D5-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B50D2-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B50D3-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B50D4-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B50CE-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B50CF-363D-11E5-9242-09173F13E4C5 n6:271B50CC-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B50CD-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B50DC-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B50DD-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B50D7-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B50D8-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B50DA-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B50D9-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B50DB-363D-11E5-9242-09173F13E4C5
n5:casRegistryNumber
3595-11-7
n5:Bioavailability
n6:271B50E1-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B50E3-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B50E4-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B50E0-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B50DF-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B50E2-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B50D1-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B50DE-363D-11E5-9242-09173F13E4C5